APAC Nerve Regeneration and Repair Market has accounted for USD 960 million in 2015 growing at a CAGR of 14.1% during the forecast years to 2022.
Asia-Pacific Nerve Regeneration and Repair Market, By Type (Biomaterials (Nerve Conduits, Nerve Protectors, Nerve Wraps, Nerve Connectors), Neurostimalation (Internal (SCS, DBS, VNS, SNS, GES), External (TENS, TMS, RES))), By Indication (Failed Back Surgery Syndrome, Parkinson’s disease, Urinary Incontinence, Epilepsy, Gastroparesis, Nerve Repair (Epineural, Perineural, Group Fascicular Repair), Grafting (Autograft, Allograft, Xenograft)), By End-User (Hospitals, Neurology Clinics, Home Healthcare, Community Healthcare), By Country (China, India, Japan, South Korea, Singapore, Thailand, Malaysia, Taiwan, Indonesia, Australia, Rest of APAC) – Trends and Forecast to 2022
The market is segmented based on product type, end-user and geography:
By Product Type:
Key Players operating in the APAC Nerve Regeneration and Repair Market:
· AxoGen Inc.
· Boston Scientific Corporation
· Medovent GmbH
· Baxter International
· Checkpoint Surgical Inc.
· St. Jude Medical, Inc.
· Integra Lifesciences Corporation
· Toyobo Co., Ltd.
· Nevro Corporation
· Orthomed S.A.S.
· Collagen Matrix, Inc.
· Cyberonics, Inc.
· Polyganics B.V.
· Stryker Corporation
Europe Internal Neuromodulation Devices Market – – Trends and Forecast to 2022
Office Number-317, Amanora Chambers,
Magarpatta Road, Hadapsar,